Compare ARQT & MANU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ARQT | MANU |
|---|---|---|
| Founded | 2016 | 1878 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Services-Misc. Amusement & Recreation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 3.0B |
| IPO Year | 2020 | 2012 |
| Metric | ARQT | MANU |
|---|---|---|
| Price | $26.62 | $19.94 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $34.00 | N/A |
| AVG Volume (30 Days) | ★ 1.8M | 307.2K |
| Earning Date | 05-06-2026 | 06-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 88.79 | N/A |
| EPS | ★ 0.03 | N/A |
| Revenue | ★ $376,072,000.00 | N/A |
| Revenue This Year | $34.85 | N/A |
| Revenue Next Year | $29.39 | $16.31 |
| P/E Ratio | $824.50 | ★ N/A |
| Revenue Growth | ★ 91.34 | N/A |
| 52 Week Low | $16.68 | $14.59 |
| 52 Week High | $31.77 | $24.45 |
| Indicator | ARQT | MANU |
|---|---|---|
| Relative Strength Index (RSI) | 51.37 | 27.73 |
| Support Level | $24.91 | $16.63 |
| Resistance Level | $25.21 | $23.85 |
| Average True Range (ATR) | 1.03 | 0.53 |
| MACD | 0.22 | -0.20 |
| Stochastic Oscillator | 59.88 | 6.61 |
Arcutis Biotherapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. Its current portfolio is comprised of differentiated topical and systemic treatments with potential to treat immune-mediated dermatological diseases and conditions. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. The Company has one reportable segment relating to the development and commercialization of treatments for dermatological diseases.
Manchester United PLC operates as a professional football club with related activities, generating revenue prominently through commercial, broadcasting, and matchday segments. The commercial segment monetizes the various brands via sponsorships, retail, merchandising, apparel, and product licensing. Broadcasting revenue comes from television rights linked to football leagues and competitions, alongside content delivered through its dedicated TV channel all over the globe. Matchday income includes ticket sales, hospitality, merchandise, and services at its stadium. Manchester United is based in England. The company's operations and fan base extends to many countries, supporting a diversified revenue model based on brand engagement and football-related content.